Recruitment

Recruitment Status
Completed

Inclusion Criteria

LDL > or = 130 mg/dl - measured during screening
Diabetes and or history of CVD
Medication Possession Ratio (MPR) <80%
...
LDL > or = 130 mg/dl - measured during screening
Diabetes and or history of CVD
Medication Possession Ratio (MPR) <80%
CVS Caremark Beneficiary
A prescription filled for statin medication within the last 12 months

Exclusion Criteria

Currently participating in another clinical trial with related aims
Contraindication to further statin use or have suffered side effects from statins, such as myopathy
Will not or cannot give consent
...
Currently participating in another clinical trial with related aims
Contraindication to further statin use or have suffered side effects from statins, such as myopathy
Will not or cannot give consent
Less than 18 years old
Co-morbidities likely to lead to death within a short-period
History of active or progressive liver disease or abnormal liver function tests on baseline screening

Summary

Conditions
Diabetes
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Single (Investigator)
  • Primary Purpose: Other

Participation Requirements

Age
Between 18 years and 80 years
Gender
Both males and females

Inclusion Criteria

LDL > or = 130 mg/dl - measured during screening
Diabetes and or history of CVD
Medication Possession Ratio (MPR) <80%
...
LDL > or = 130 mg/dl - measured during screening
Diabetes and or history of CVD
Medication Possession Ratio (MPR) <80%
CVS Caremark Beneficiary
A prescription filled for statin medication within the last 12 months

Exclusion Criteria

Currently participating in another clinical trial with related aims
Contraindication to further statin use or have suffered side effects from statins, such as myopathy
Will not or cannot give consent
...
Currently participating in another clinical trial with related aims
Contraindication to further statin use or have suffered side effects from statins, such as myopathy
Will not or cannot give consent
Less than 18 years old
Co-morbidities likely to lead to death within a short-period
History of active or progressive liver disease or abnormal liver function tests on baseline screening

Tracking Information

NCT #
NCT02086539
Collaborators
  • Rutgers University
  • National Institute on Aging (NIA)
Investigators
  • Principal Investigator: Kevin G Volpp, MD, PhD University of Pennsylvania
  • Kevin G Volpp, MD, PhD University of Pennsylvania